416 related articles for article (PubMed ID: 29338854)
1. Long-term outcomes in cancer patients who did or did not pursue fertility preservation.
Moravek MB; Confino R; Smith KN; Kazer RR; Klock SC; Lawson AK; Gradishar WJ; Pavone ME
Fertil Steril; 2018 Feb; 109(2):349-355. PubMed ID: 29338854
[TBL] [Abstract][Full Text] [Related]
2. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria.
Meirow D; Ra'anani H; Shapira M; Brenghausen M; Derech Chaim S; Aviel-Ronen S; Amariglio N; Schiff E; Orvieto R; Dor J
Fertil Steril; 2016 Aug; 106(2):467-74. PubMed ID: 27181924
[TBL] [Abstract][Full Text] [Related]
3. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.
Creux H; Monnier P; Son WY; Buckett W
J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188
[TBL] [Abstract][Full Text] [Related]
4. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
5. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
[TBL] [Abstract][Full Text] [Related]
6. Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients.
Massarotti C; Scaruffi P; Lambertini M; Sozzi F; Remorgida V; Anserini P
Hum Reprod; 2019 Aug; 34(8):1462-1469. PubMed ID: 31339999
[TBL] [Abstract][Full Text] [Related]
7. Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation.
Moravek MB; Confino R; Lawson AK; Smith KN; Kazer RR; Klock SC; Gradishar WJ; Jeruss JS; Pavone ME
Breast Cancer Res Treat; 2021 Apr; 186(2):429-437. PubMed ID: 33392838
[TBL] [Abstract][Full Text] [Related]
8. Ovarian stimulation in young adult cancer survivors on targeted cancer therapies.
Su HI; Connell MW; Bazhenova LA
Fertil Steril; 2016 Nov; 106(6):1475-1478. PubMed ID: 27565250
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
10. Long term pregnancy outcomes of women with cancer following fertility preservation: A systematic review and meta-analysis.
Xu Z; Ibrahim S; Burdett S; Rydzewska L; Al Wattar BH; Davies MC
Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():41-48. PubMed ID: 36535069
[TBL] [Abstract][Full Text] [Related]
11. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
12. Expanding Urgent Oncofertility Services for Reproductive Age Women Remote from a Tertiary Level Fertility Centre by Use of Telemedicine and an On-site Nurse Navigator.
Zwingerman R; Melenchuk K; McMahon E; Liu KE; Siren A; Laferriere N; Greenblatt EM
J Cancer Educ; 2020 Jun; 35(3):515-521. PubMed ID: 30820926
[TBL] [Abstract][Full Text] [Related]
13. First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination.
Shapira M; Raanani H; Barshack I; Amariglio N; Derech-Haim S; Marciano MN; Schiff E; Orvieto R; Meirow D
Fertil Steril; 2018 Jan; 109(1):48-53. PubMed ID: 29198847
[TBL] [Abstract][Full Text] [Related]
14. Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience.
Mayeur A; Puy V; Windal V; Hesters L; Gallot V; Benoit A; Grynberg M; Sonigo C; Frydman N
J Assist Reprod Genet; 2021 Jul; 38(7):1767-1775. PubMed ID: 33797007
[TBL] [Abstract][Full Text] [Related]
15. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
Creux H; Monnier P; Son WY; Tulandi T; Buckett W
Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
[TBL] [Abstract][Full Text] [Related]
16. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
[TBL] [Abstract][Full Text] [Related]
17. Experiences in fertility preservation: lessons learned to ensure that fertility and reproductive autonomy remain options for cancer survivors.
Noyes N; Melzer K; Druckenmiller S; Fino ME; Smith M; Knopman JM
J Assist Reprod Genet; 2013 Oct; 30(10):1263-70. PubMed ID: 23942892
[TBL] [Abstract][Full Text] [Related]
18. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
[TBL] [Abstract][Full Text] [Related]
19. Gestational carrier in assisted reproductive technology.
Murugappan G; Farland LV; Missmer SA; Correia KF; Anchan RM; Ginsburg ES
Fertil Steril; 2018 Mar; 109(3):420-428. PubMed ID: 29428314
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Stimulation Is Safe and Effective for Patients with Gynecologic Cancer.
Akel RA; Guo XM; Moravek MB; Confino R; Smith KN; Lawson AK; Klock SC; Tanner Iii EJ; Pavone ME
J Adolesc Young Adult Oncol; 2020 Jun; 9(3):367-374. PubMed ID: 31923372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
